CL
JAZZ icon

CSS LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

CSS LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,600
Closed -$243K – 1111
2022
Q2 		$250K Sell
1,600
-5,491
-77% -$845K 0.01% 762
2022
Q1 		$1.1M Buy
7,091
+1,013
+17% +$147K 0.04% 406
2021
Q4 		$774K Buy
6,078
+2,700
+80% +$355K 0.03% 512
2021
Q3 		$440K Hold
3,378
– – 0.02% 672
2021
Q2 		$600K Buy
+3,378
New +$585K 0.02% 576

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CSS LLC's JAZZ Position: Q3 2022 in Review

CSS LLC sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2022, closing a stake of 1,600 shares — an estimated $243K sold.

CSS LLC first reported a position in JAZZ in Q2 2021 and held it in 5 quarters. The position peaked at $1.1M in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.

  • CSS LLC reported no remaining Jazz Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CSS LLC sold 1,600 Jazz Pharmaceuticals shares in Q3 2022, an estimated $243K.
  • CSS LLC first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • CSS LLC's Jazz Pharmaceuticals position peaked at $1.1M in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.